{
    "2019-07-23": [
        [
            {
                "time": "2019-07-23",
                "original_text": "Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Q2 Earnings",
                        "Sales Beat",
                        "Raised View"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "Here's Why the Best Is Yet to Come for UroGen Pharma",
                "features": {
                    "keywords": [
                        "UroGen Pharma",
                        "Best Is Yet to Come"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "SPLG, JNJ, T, WMT: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow Alert",
                        "SPLG",
                        "JNJ",
                        "T",
                        "WMT"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Humira",
                        "Drugs",
                        "AbbVie",
                        "Q2 Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "3 of the Most Rock-Solid Dividend Stocks in the World",
                "features": {
                    "keywords": [
                        "Rock-Solid",
                        "Dividend Stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Microsoft",
                        "JPMorgan",
                        "Merck",
                        "Johnson & Johnson",
                        "IBM"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-23",
                "original_text": "Drugmakers shell out record amount lobbying Congress",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "Lobbying",
                        "Congress"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}